• S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

  • Jan 12 2024
  • Length: 22 mins
  • Podcast
S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments By cover art

S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

Listen for free

View show details

  • Summary

  • In this episode, our faculty take a deeper dive into their discussion of treatments of neovascular AMD, including anti-VEGF agents and some of the newer agents, including a bispecific antibody that inhibits both VEGF and Ang2.

    Visit www.morningcommutepodcast.com/AMD2 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
    Show more Show less
Show more Show less

What listeners say about S1E2 - Ophthalmology Morning Commute: New Clinical Approaches and Sequencing of Age-Related Macular Degeneration Treatments

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available